Vitamin D Deficiency: 2026 Levels, Symptoms, and Supplementation

What vitamin D actually is

Vitamin D is only loosely a "vitamin." A true vitamin is something the body cannot make and must obtain from food. Vitamin D is different: given enough sunlight, human skin manufactures nearly all of it. Chemically it is a secosteroid — a hormone precursor built on the same cholesterol backbone as your sex and stress hormones. That single fact explains most of what follows, from why a summer beach holiday can normalize a level to why the active form is tightly controlled rather than free-floating.

There are two dietary and supplemental forms. Vitamin D3 (cholecalciferol) is the form your skin makes and the form found in oily fish and animal foods; vitamin D2 (ergocalciferol) comes from fungi and some fortified foods. Neither form is biologically active as swallowed or synthesized. The body activates vitamin D in two steps. First the liver adds a hydroxyl group to produce 25-hydroxyvitamin D (25-OH D, or calcidiol) — the long-lived circulating form that laboratories measure and the subject of this entire guide. Then the kidney performs a second hydroxylation to produce 1,25-dihydroxyvitamin D (calcitriol), the fully active hormone.

Why do labs measure 25-OH D rather than the active hormone? Because 25-OH D has a half-life of roughly two to three weeks and reflects your accumulated stores from sun, diet, and supplements. Calcitriol, by contrast, has a half-life measured in hours and is held on a short leash by parathyroid hormone, calcium, and phosphate. In early deficiency, the body compensates by cranking up activation, so calcitriol can look deceptively normal even as stores run dry. Measuring the active form to assess status is therefore a classic beginner's error. The one marker that honestly tracks whether you have enough vitamin D on board is 25-hydroxyvitamin D.

Functionally, vitamin D's best-established job is orchestrating calcium and phosphate homeostasis: it increases intestinal calcium absorption, supports bone mineralization, and — with parathyroid hormone — keeps blood calcium in its narrow safe range. Beyond bone, vitamin D receptors appear on immune cells, muscle, and many other tissues, which is why the marker is casually linked to immunity, mood, and muscle strength. As we will see, the bone story is rock-solid; several of the popular extraskeletal claims are considerably softer than the internet suggests.

Vitamin D levels and cutoffs (2026)

Here is where honest reporting matters, because the experts genuinely disagree. The thresholds below reflect the widely used clinical framework popularized by the Endocrine Society, which treats 30 ng/mL as the target for sufficiency. Most reference laboratories, including the range attached to this result, use a similar 30–100 ng/mL sufficiency window.

Now the disagreement. The U.S. National Academies of Sciences, Engineering, and Medicine (NASEM, formerly the Institute of Medicine) concluded that a 25-OH D of 20 ng/mL (50 nmol/L) already meets the needs of at least 97.5% of the population for bone health, and that levels above that confer little additional skeletal benefit. The Endocrine Society, writing for patients already at risk, set the bar at 30 ng/mL. The United Kingdom's NICE and Scientific Advisory Committee on Nutrition frame the problem around 25 nmol/L (10 ng/mL) as the threshold below which musculoskeletal disease risk clearly rises. So a person at 24 ng/mL can be simultaneously "insufficient" (Endocrine Society) and "adequate" (NASEM). Neither is wrong; they answer slightly different questions.

A 2024 Endocrine Society clinical practice guideline update went further, cautioning that routine testing and treatment to a specific target is not clearly beneficial for healthy adults under 75, and instead emphasized empiric low-dose supplementation for groups most likely to benefit. The U.S. Preventive Services Task Force (USPSTF) reached a related conclusion in 2021: there is insufficient evidence to recommend screening asymptomatic, community-dwelling adults for vitamin D deficiency at all. The practical takeaway: cutoffs are tools, not verdicts. A number below 30 is a prompt to think, not a diagnosis.

How vitamin D is measured

The test on your report is "25-hydroxyvitamin D, total," and total matters: it should capture both 25-OH-D2 and 25-OH-D3. Two broad assay families are in use, and they do not always agree. Immunoassays (the automated antibody-based platforms most large labs run) are fast and cheap but can under-recover D2 and are sensitive to the vitamin D binding protein. Liquid chromatography–tandem mass spectrometry (LC-MS/MS) is the reference method, separately quantifying D2 and D3 with high accuracy, and is preferred when a result is borderline, a patient takes D2 (prescription ergocalciferol), or numbers do not fit the clinical picture.

Historically, vitamin D assays were notoriously inconsistent between labs — the same sample could read 18 ng/mL in one lab and 28 in another. That is why the Vitamin D Standardization Program (VDSP), run with the CDC and NIH, and the international DEQAS quality-assurance scheme exist, working toward reference measurement procedures traceable to standards from the IFCC and NIST. In 2026, a lab that participates in standardization gives you a far more comparable number. This is directly relevant if you are tracking a level over time: try to use the same laboratory and method for serial measurements, and be cautious comparing a value from one provider against a threshold quoted by another.

Timing and biology add further nuance. Vitamin D shows a strong seasonal rhythm in temperate climates, typically peaking in late summer and troughing in late winter and early spring, so the month you test changes the story. A single low reading in March does not carry the same weight as a low reading in September. The test does not require fasting. Pediatric interpretation deserves its own ranges: initiatives such as CALIPER (Canada) and Nordic NORIP-style reference work exist precisely because children's biochemistry is not a scaled-down adult's. Rapid growth also raises alkaline phosphatase, which interacts with the vitamin D–bone picture.

• Test 'total' 25-OH D, which includes D2 and D3 — not the active 1,25-dihydroxy form (reserved for specialist scenarios like sarcoidosis or certain kidney disorders).
• Prefer LC-MS/MS for borderline results, D2 users, or when the number contradicts symptoms.
• Stay with one lab and method when trending a level across months or years.
• Note the season — a winter trough and a summer peak are not comparable.
• No fasting needed, and recent supplement doses within hours barely move a two-to-three-week storage marker.

Symptoms of deficiency

The uncomfortable truth is that mild-to-moderate vitamin D deficiency is usually silent. Many people with a level of 15–19 ng/mL feel entirely well, which is exactly why deficiency is so common and why the USPSTF questions blanket screening. Symptoms, when they appear, are non-specific — they overlap with thyroid disease, iron deficiency, depression, and simple overwork — so a symptom list is a prompt to test, never a substitute for the number.

• Bone or deep muscle aches that resist ordinary treatment (a hallmark of osteomalacia, the adult equivalent of rickets)
• Proximal muscle weakness and difficulty rising from a chair or climbing stairs — vitamin D myopathy
• Frequent infections, particularly upper respiratory ones
• Persistent fatigue not explained by sleep or workload
• Low mood, sometimes in a seasonal pattern
• Hair thinning
• Slow wound healing
• In children: bowed legs, delayed growth, and skeletal deformity (frank rickets)

At the severe end — sustained levels below roughly 10 ng/mL — the consequences become concrete and medical rather than vague. Adults can develop osteomalacia, in which new bone fails to mineralize properly, producing bone pain, tenderness, pseudofractures, and a waddling gait. Children can develop rickets, a preventable cause of permanent skeletal deformity that the WHO still tracks in vulnerable populations. These are the outcomes the reference cutoffs are ultimately designed to prevent, and they are the reason severe deficiency is treated promptly and confidently even when milder deficiency is debated.

Why levels go low (and high)

Vitamin D status is a balance between inputs (sun, diet, supplements), the machinery that activates and stores it, and factors that dilute or sequester it. Deficiency almost always comes down to reduced skin synthesis plus low intake, but malabsorption, organ disease, and medications are important secondary causes that change the treatment plan entirely.

High vitamin D is much rarer and almost always human-made: over-supplementation is the dominant cause of a level above 100 ng/mL. Genuine toxicity is a story of megadoses (typically sustained intake above 10,000 IU/day, or manufacturing/dosing errors), not of sensible daily supplements or sunshine — the skin self-limits its own production, so you cannot overdose from the sun. A less common but important cause of a high active-hormone state is granulomatous disease such as sarcoidosis or tuberculosis, where immune cells convert vitamin D to calcitriol unchecked and drive up blood calcium. That is one of the few scenarios where a clinician measures the active 1,25-dihydroxy form rather than 25-OH D.

Who is most at risk

Deficiency is not randomly distributed. Certain groups are predictably low and are exactly the people the 2024 Endocrine Society guidance suggests may benefit from empiric supplementation without necessarily testing first. If you belong to several of these categories, a low result should surprise no one.

Geography and season compound these. Above roughly 37° latitude — most of Europe, Canada, the northern United States — the winter sun sits too low for skin to make meaningful vitamin D for several months, so nearly everyone drifts downward from December to March regardless of skin type. Public health bodies including the UK's NHS respond to this with population advice to consider a daily 10 µg (400 IU) supplement through autumn and winter, precisely because sun cannot fill the gap in that window.

Related labs: calcium, PTH, magnesium

A 25-OH D value read in isolation is a single instrument in an orchestra. Vitamin D's core job is calcium regulation, so its real clinical meaning emerges only alongside calcium, phosphate, parathyroid hormone (PTH), and alkaline phosphatase. The single most important pattern to understand is secondary hyperparathyroidism: when vitamin D is low, the gut absorbs less calcium, blood calcium tends to fall, and the parathyroid glands respond by raising PTH to pull calcium out of bone. So a truly consequential deficiency often shows low-normal calcium, a high PTH, and — over time — a rising alkaline phosphatase as bone turnover accelerates. That constellation carries far more weight than the vitamin D number alone.

Two often-overlooked partners deserve emphasis. First, magnesium: it is a required cofactor for the enzymes that activate vitamin D and for PTH action. Chronic magnesium deficiency — common with diuretics, alcohol use, proton-pump inhibitors, and poorly controlled diabetes — can make vitamin D supplementation stubbornly ineffective, and correcting magnesium sometimes unlocks a level that would not budge. Second, vitamin B12 and iron: fatigue attributed to "low vitamin D" is frequently multi-factorial, and a thorough panel checks whether B12 or iron deficiency is the true driver. Our companion guide on iron deficiency anemia walks through that overlapping fatigue picture in detail.

Conditions linked to vitamin D

This is the section where evidence and enthusiasm diverge most, so it is worth being precise. Vitamin D's benefits fall into two tiers: a skeletal tier that is well proven, and an extraskeletal tier that is heavily studied, widely marketed, and — for hard outcomes — mostly unconvincing in high-quality trials.

The proven, skeletal tier

Severe, sustained deficiency causes rickets in children and osteomalacia in adults — this is not controversial, and it is the foundation of every reference range. Beyond frank disease, correcting deficiency supports bone mineral density and, in combination with adequate calcium, reduces fracture and fall risk in older, deficient, or institutionalized populations. This is why fracture-prevention and osteoporosis guidance from bodies such as the Endocrine Society and NICE consistently include vitamin D as a supporting player alongside calcium, weight-bearing activity, and bone-specific therapy.

The contested, extraskeletal tier

For years, observational studies linked low vitamin D to almost everything — cancer, heart disease, infections, depression, autoimmune disease. But observational associations are notoriously vulnerable to reverse causation: sick, frail, or housebound people are both low in vitamin D and more likely to have poor outcomes, so low D may be a marker of ill health rather than a cause. The landmark VITAL trial (over 25,000 adults, 2,000 IU/day) found that vitamin D supplementation did not reduce overall cancer incidence or major cardiovascular events versus placebo. Large trials such as D2d found no reduction in progression from prediabetes to type 2 diabetes at the population level. Meta-analyses do suggest a modest reduction in acute respiratory infections, strongest in people who were genuinely deficient to begin with, and there are intriguing but not-yet-practice-changing signals for autoimmune disease.

None of this is a diagnosis, and none of it replaces a clinician. blood-test.life is an educational publication and its analyzer is not a medical device; if you have symptoms, a personal or family history of relevant disease, or an abnormal calcium or PTH, that warrants a professional evaluation rather than a self-directed supplement plan.

Supplementation and dosing

When repletion is warranted, the goal is simple: refill stores safely, confirm with a retest, then settle onto a maintenance dose. Adult guidance varies by jurisdiction, and the figures below reflect commonly used ranges rather than a personal prescription — dosing should be individualized, especially with kidney disease, granulomatous disease, or a high calcium.

A few practical points. D3 (cholecalciferol) is generally preferred to D2 because it raises and maintains 25-OH D somewhat more effectively; prescription-strength D2 remains common and works, particularly for high-dose repletion. Take it with a fat-containing meal — vitamin D is fat-soluble and absorption improves. Because it is a storage marker, daily and weekly regimens both work, but very large intermittent bolus doses (for example, a single annual megadose) have in some trials paradoxically been associated with more falls and are generally discouraged. Address magnesium status if a level refuses to rise. And crucially: retest after 8–12 weeks of repletion — long enough for the two-to-three-week half-life to reach a new steady state — rather than chasing the number weekly.

On the popular add-ons: the evidence for routinely pairing vitamin D with vitamin K2 to "direct calcium to bone" is biologically plausible but not yet strong enough for a blanket recommendation. High-dose calcium supplementation, on the other hand, deserves caution and a clinician's input given cardiovascular and kidney-stone debates. The safest posture is food-first calcium, sensible vitamin D, and dosing anchored to a measured level rather than to marketing.

How AI reads vitamin D in context

A number on a page is easy to over- or under-react to. The point of the Kantesti AI engine behind blood-test.life's analyzer is not to replace the reference range but to read your vitamin D the way an experienced clinician would — in context. A standalone 25-OH D of 22 ng/mL is 'insufficient' by one ruler and 'adequate' by another; the meaning changes entirely depending on the company it keeps.

• Pattern over single values: the engine cross-references vitamin D against calcium, PTH (when available), ALP, and magnesium to flag the secondary-hyperparathyroidism pattern that turns a mild-looking deficiency into a meaningful one.
• Context weighting: season, age, likely skin type, and stated risk factors shift how much a borderline value matters — a March 19 ng/mL in a housebound older adult reads differently from a September 19 ng/mL in a young athlete.
• Trend awareness: when you upload serial results, it looks at direction and rate of change, and it respects the two-to-three-week half-life instead of over-interpreting week-to-week noise.
• Guideline transparency: it can show you where the Endocrine Society, NASEM, and USPSTF diverge on your specific number, rather than pretending a single universal cutoff exists.
• Guardrails: it is explicit about what it is not — not a diagnosis, not a prescription, and not a substitute for a clinician when calcium is high or symptoms are severe.

If you want the mechanics of how results are parsed, normalized across labs, and explained, see how it works. You can also browse every marker discussed here — and its partner labs — in the biomarker library, or review plans on the pricing page. The engine is a literacy tool: it helps you arrive at a conversation with your clinician already understanding what your numbers mean.

When to see a clinician

Self-education has limits, and a few situations should route you to a professional rather than a supplement aisle. Treat the following as reasons to book an appointment rather than to interpret alone:

• A high calcium on any panel, whether or not vitamin D is high — this needs evaluation (hyperparathyroidism, malignancy, sarcoidosis, or toxicity).
• A very low vitamin D (< 10 ng/mL) or symptoms of osteomalacia: bone pain, muscle weakness, difficulty walking.
• Any suspicion of rickets in a child — bowed legs, delayed growth, skeletal deformity.
• Known kidney or liver disease, malabsorption, or bariatric surgery, where standard dosing may be wrong.
• A high vitamin D with symptoms of toxicity: nausea, excessive thirst and urination, confusion, or palpitations.
• A deficiency that will not correct despite adherent supplementation — this may signal malabsorption or untreated magnesium deficiency.
• Pregnancy, or dosing questions for an infant — dosing there is specific and worth confirming.

Myths and misconceptions

"Everyone should test and aim for a high level."

The USPSTF found insufficient evidence to screen asymptomatic adults, and the best trials show no benefit to pushing an already-adequate level higher. Testing is most useful when you have symptoms or risk factors. There is no prize for a 25-OH D of 80 over 40.

"Vitamin D prevents cancer and heart disease."

The large VITAL trial says otherwise for hard outcomes. Fix a real deficiency for your bones and muscles; do not take vitamin D as a cardiovascular or cancer drug, because at population scale it isn't one.

"You can get toxic from too much sun."

You cannot. Skin synthesis is self-limiting — excess pre-vitamin D is degraded by the same UV light. Toxicity comes from supplements, essentially never from sunlight. (Sun still carries skin-cancer risk, which is a separate reason not to bake for vitamin D.)

"D2 and D3 are interchangeable."

Both raise your level, but D3 does so more efficiently and durably in most studies, and some total-D immunoassays under-read D2. If you take prescription D2, an LC-MS/MS 'total' assay gives the fairest reading.

"My fatigue is definitely the low vitamin D."

Maybe — but low-D symptoms are generic. Iron, B12, thyroid, sleep, and mood all produce similar fatigue. If repletion doesn't fix it, keep looking. See the thyroid panel guide for one very common alternative explanation.

Lifestyle and next steps

Vitamin D status responds to a small number of high-leverage habits, most of which cost nothing. The aim is a steady, adequate level year-round — not a spectacular number.

1. Know your number in context. Read your 25-OH D alongside calcium and, when available, PTH and ALP — not as a lonely value against a single cutoff.
2. Get sensible sun in season. At temperate latitudes, short midday exposure of face and arms a few times a week in spring and summer helps; avoid burning, which raises skin-cancer risk without adding vitamin D.
3. Eat the food sources. Oily fish (salmon, mackerel, sardines), egg yolks, and fortified foods contribute, though diet alone rarely fills a real deficit.
4. Supplement to a measured level, especially in winter. A daily 1,000–2,000 IU D3 is a reasonable maintenance range for many adults; higher-latitude winter populations often follow the 400 IU/day public-health floor.
5. Address the cofactors. Correct magnesium if levels won't rise, and rule out iron and B12 as alternative causes of fatigue.
6. Retest, don't chase. Recheck 8–12 weeks after starting repletion, then only as clinically indicated — the marker has a weeks-long memory.
7. Escalate the red flags. High calcium, severe symptoms, non-responding deficiency, or organ disease belong with a clinician, not a search engine.

Used well, your vitamin D result is a genuinely useful window into bone and mineral health and a cheap, correctable deficiency. Used badly, it becomes a number you obsess over and megadose toward for benefits that trials do not support. The middle path — fix real deficiency, respect the biology, retest sensibly, and bring anything alarming to a professional — is where the evidence actually lives.

Frequently asked questions